Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Hwang (Taoyuan, Taiwan). Dipeptide HCH6-1 inhibits neutrophil activation and protects against acute lung injury by blocking FPR1. 1044

Member's Comments

No comment yet.

Related content which might interest you: Inhibition of neutrophil apoptosis by sphingosin-1-phopsphate through the activation of neutral sphingomyelinase in acute lung injury Source: Annual Congress 2010 - Emerging mechanisms in lung injury Year: 2010 Effect of curcumin on LPS-induced neutrophil activation and acute lung injury Source: Annual Congress 2012 - Lung injury, respiratory muscles and mechanical ventilation Year: 2012 Ethyl pyruvate prevents lung injury through inhibition of the NF-kappa B pathway, but does not prevent bleomycin-induced lung injury Source: Annual Congress 2010 - New insights into reactive oxygen species Year: 2010 Pioglitazone attenuates endotoxin-induced acute lung injury by reducing neutrophil recruitment Source: Eur Respir J 2012; 40: 416-423 Year: 2012 Effects of autophagy on LPS-induced lung inflammation and acute lung injury (ALI) in vitro and in vivo Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury Year: 2018 Gabexate mesilate attenuates ischemia-reperfusion injury of lung grafts via the inhibition of neutrophil activation Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation Year: 2005 Hsp90 binding inhibitors improve survival in a murine model of sepsis induced acute lung injury Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS) Year: 2006 Kallistatin protects against LPS-induced mouse lung injury Source: Annual Congress 2012 - The many roads to lung injury Year: 2012 Tetracycline alleviates acute lung injury by inhibition of NLRP3 inflammasome Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure Year: 2019 RAGE deficiency improves alveolar fluid clearance in LPS-induced acute lung injury by preventing downregulation of Na-K-ATPase and ENaC Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury Year: 2017 Inhibition of neutrophil elastase contributes to attenuationof lipopolysaccharide-induced acute lung injuryduring neutropenia recovery in mice Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury Year: 2017 CD101 eosinophil serves as an early response to suppress endotoxin-induced acute lung injury Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury Year: 2018 Evidence that cathepsin G counteracts the profibrotic effects of neutrophil elastase following lung injury Source: Eur Respir J 2001; 18: Suppl. 33, 181s Year: 2001 Phosphoinositide 3-kinase γ required for lipopolysaccharide-induced transepithelial neutrophil trafficking in the lung Source: Eur Respir J 2010; 35: 1137-1147 Year: 2010 Activated protein C protection in endotoxin-induced lung injury is mediated by lung matrix metalloproteinases activity Source: Annual Congress 2007 - Miscellaneous lower respiratory tract infections Year: 2007 Sirtuins inhibition modulates endotoxin-induced lung inflammation Source: Annual Congress 2010 - Models of airways disease Year: 2010 A role for PAR1 in lipopolysaccharide induced acute lung injury Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon Year: 2008 Surfactant protein A modulate bleomycin-induced lung injury in toll-like receptor 2 dependent pathway Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis Year: 2010 Amifostine reduces lipopolysaccharide-induced lung dysfunction via suppression of redox-sensitive inflammatory signaling Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies Year: 2008 Deficiency or inhibition of lysophosphatidic acid receptor 1 protects against hyperoxia-induced lung injury in neonatal rats Source: International Congress 2015 – Neonatal and paediatric intensive care Year: 2015